Search PepX: dna-binding
Results 1 - 50 of 53
Results
| PDB Identifier | Description | Ligand | Receptor | SCOP | pdb.org | |
|---|---|---|---|---|---|---|
  |
1GWQ | HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE | C | A | Nuclear receptor ligand-binding domain |
 |
  |
1GWR | HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE | C | A | Nuclear receptor ligand-binding domain |
|
  |
1YCQ | XENOPUS LAEVIS MDM2 BOUND TO THE TRANSACTIVATION DOMAIN OF HUMAN P53 | B | A | SWIB/MDM2 domain |
|
  |
2BJ4 | ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST | C | A |
|
|
  |
2J7X | STRUCTURE OF ESTRADIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 | B | A | Nuclear receptor ligand-binding domain |
|
  |
2J7Y | STRUCTURE OF 17-EPIESTRIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 | B | A | Nuclear receptor ligand-binding domain |
|
  |
2JF9 | ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST | P | AC |
|
|
  |
2QPY | AR LBD with small molecule | B | A | Nuclear receptor ligand-binding domain |
|
  |
2QR9 | Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with an Oxabicyclic Derivative Compound | C | A |
|
|
  |
2QSE | Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain complexed with Burned Meat Compound 4-OH-PhIP | C | A |
|
|
  |
2QXM | Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Burned Meat Compound PhIP | C | A |
|
|
  |
2QXV | Structural basis of EZH2 recognition by EED | B | A |
|
|
  |
2QZO | Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with WAY-169916 | C | A |
|
|
  |
2W9R | STRUCTURAL BASIS OF N-END RULE SUBSTRATE RECOGNITION IN ESCHERICHIA COLI BY THE CLPAP ADAPTOR PROTEIN CLPS | B | A |
|
|
  |
2Z5S | Molecular basis for the inhibition of p53 by Mdmx | R | O |
|
|
  |
2Z5T | Molecular basis for the inhibition of p53 by Mdmx | P | MO |
|
|
  |
2ZFX | Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR301 and a synthetic peptide containing the NR2 box of DRIP 205 | C | A |
|
|
  |
2ZL9 | 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure | C | A | Nuclear receptor ligand-binding domain |
|
  |
2ZLA | 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure | C | A | Nuclear receptor ligand-binding domain |
|
  |
2ZLC | 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure | C | A | Nuclear receptor ligand-binding domain |
|
  |
2ZMH | Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism | C | A | Nuclear receptor ligand-binding domain |
|
  |
2ZMI | Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism | C | A | Nuclear receptor ligand-binding domain |
|
  |
2ZMJ | Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism | C | A | Nuclear receptor ligand-binding domain |
|
  |
2ZVV | Crystal structure of Proliferating cellular nuclear antigen 1 and Short peptide from human P21 | X | YAB |
|
|
  |
2ZXN | A New Class of Vitamin D Receptor Ligands that Induce Structural Rearrangement of the Ligand-binding Pocket | C | A |
|
|
  |
3BEJ | Structure of human FXR in complex with MFA-1 and co-activator peptide | E | A | Nuclear receptor ligand-binding domain |
|
  |
3BQD | Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol | B | A | Nuclear receptor ligand-binding domain |
|
  |
3BQO | Crystal Structure of TRF1 TRFH domain and TIN2 peptide complex | B | A | Telomeric repeat binding factor (TRF) dimerisation domain |
|
  |
3BU8 | Crystal Structure of TRF2 TRFH domain and TIN2 peptide complex | D | B | Telomeric repeat binding factor (TRF) dimerisation domain |
|
  |
3BUA | Crystal Structure of TRF2 TRFH domain and APOLLO peptide complex | F | B | Telomeric repeat binding factor (TRF) dimerisation domain |
|
  |
3C2G | Crystal complex of SYS-1/POP-1 at 2.5A resolution | C | A |
|
|
  |
3CS8 | Structural and Biochemical Basis for the Binding Selectivity of PPARg to PGC-1a | B | A | Nuclear receptor ligand-binding domain |
|
  |
3CWD | Molecular recognition of nitro-fatty acids by PPAR gamma | C | A | Nuclear receptor ligand-binding domain |
|
  |
3D24 | Crystal structure of ligand-binding domain of estrogen-related receptor alpha (ERRalpha) in complex with the peroxisome proliferators-activated receptor coactivator-1alpha box3 peptide (PGC-1alpha) | B | A | Nuclear receptor ligand-binding domain |
|
  |
3DAB | Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain | D | C |
|
|
  |
3DAC | Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain | P | M |
|
|
  |
3DCT | FXR with SRC1 and GW4064 | B | A | Nuclear receptor ligand-binding domain |
|
  |
3E7C | Glucocorticoid Receptor LBD bound to GSK866 | D | B |
|
|
  |
3E94 | Crystal structure of RXRalpha ligand binding domain in complex with tributyltin and a coactivator fragment | B | A |
|
|
  |
3ECH | The MarR-family repressor MexR in complex with its antirepressor ArmR | C | BA |
|
|
  |
3ET1 | Structure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid | P | A |
|
|
  |
3ET3 | Structure of PPARgamma with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid | P | A |
|
|
  |
3F7D | SF-1 LBD bound by phosphatidylcholine | B | A |
|
|
  |
3F9W | Structural Insights into Lysine Multiple Methylation by SET Domain Methyltransferases, SET8-Y334F / H4-Lys20 / AdoHcy | F | AB |
|
|
  |
3F9Z | Structural Insights into Lysine Multiple Methylation by SET Domain Methyltransferases, SET8-Y245F / H4-Lys20 / AdoHcy | G | A |
|
|
  |
3FUG | Crystal Structure of the Retinoid X Receptor Ligand Binding Domain Bound to the Synthetic Agonist 3-[4-Hydroxy-3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-phenyl]acrylic Acid | B | A |
|
|
  |
3FUR | Crystal Structure of PPARg in complex with INT131 | H | A |
|
|
  |
3FXV | Identification of an N-oxide pyridine GW4064 analogue as a potent FXR agonist | B | A |
|
|
  |
3G8I | Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes | Z | A |
|
|
  |
3G9E | Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes | B | A |
|
